Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

AIF (IN) polyclonal antibody

ADI-AAP-015-E 100 µg 316.00 USD
Do you need bulk/larger quantities?

Product Specification

Alternative Name:Apoptosis-inducing factor
Immunogen:Synthetic peptide corresponding to a portion of human AIF .
UniProt ID:O95831
GenBank ID:AAD16436
Species reactivity:Human, Mouse, Rat
Recommended Dilutions/Conditions:Western Blot (0.25-1.0µg/ml)
Suggested dilutions/conditions may not be available for all applications.
Optimal conditions must be determined individually for each application.
Application Notes:Detects a band of ~67kDa by Western blot.
Purity Detail:Ion exchange purified.
Formulation:Liquid. In PBS containing 0.02% sodium azide.
Shipping:Blue Ice Not Frozen
Long Term Storage:+4°C
Scientific Background:Apoptosis inducing factor (AIF) is a mitochondrial inter-membrane flavoprotein that is ubiquitously expressed both in normal tissues and in a variety of cancer cell lines. AIF is synthesized as a nonapoptogenic precursor in the cytoplasm and efficiently imported into the mitochondrial inter-membrane space. Mature AIF protein is normally confined to the mitochondrial inter-membrane space. In a variety of different apoptosis-inducing conditions AIF translocates through the outer mitochondrial membrane to the cytosol and to the nucleus. Extra-mitochondrial AIF induces nuclear chromatin condensation and large scale (~50kb) DNA fragmentation.
AIF (IN) polyclonal antibody Western blot
Western blot analysis of human K562 cell lysates (A), rat (B), and mouse (C) heart tissue using AIF (IN) pAb at 1µg/ml.
Please mouse over
AIF (IN) polyclonal antibody Western blot

Product Toolbox


Certificate of Analysis


By target:
Apoptosis-inducing factor
By biological activity:
Apoptosis-inducing factor Polyclonal antibody
By catalog section:


Technical Service
Customer Service

Recommend this page

For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2019 Enzo Life Sciences, Inc.,